Makoto Morimoto

5.6k total citations · 2 hit papers
71 papers, 5.1k citations indexed

About

Makoto Morimoto is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Makoto Morimoto has authored 71 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 24 papers in Toxicology and 21 papers in Organic Chemistry. Recurrent topics in Makoto Morimoto's work include Bioactive Compounds and Antitumor Agents (24 papers), Cancer therapeutics and mechanisms (23 papers) and Microbial Natural Products and Biosynthesis (19 papers). Makoto Morimoto is often cited by papers focused on Bioactive Compounds and Antitumor Agents (24 papers), Cancer therapeutics and mechanisms (23 papers) and Microbial Natural Products and Biosynthesis (19 papers). Makoto Morimoto collaborates with scholars based in Japan, Singapore and United States. Makoto Morimoto's co-authors include Tatsuya Tamaoki, Fusao Tomita, ISAMI TAKAHASHI, Yuzuru Kato, Hirofumi Nakano, Eiji Kobayashi, Katsushige Gomi, Masami Okabe, Isao Kawamoto and Kozo Asano and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Makoto Morimoto

71 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase

1986 2.3k citations Tatsuya Tamaoki, ISAMI TAKAHASHI et al. profile →
Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C

1989 1.1k citations Hirofumi Nakano, Makoto Morimoto et al. profile →

Peers

Makoto Morimoto

PHARM

ONCOL

IMMUN

ISAMI TAKAHASHI Japan

Tatsuya Tamaoki Japan

Hirofumi Nakano Japan

Marc Labelle Canada

Michel Gallant Canada

Christoph Schächtele Germany

Ronald L. Magolda United States

Yuzuru Matsuda Japan

Gary L. Firestone United States

Megan J. Robinson United States

ISAMI TAKAHASHI Japan

Makoto Morimoto

3.2k ×1.0

711 ×0.8

499 ×0.7

PHARM

605 ×0.9

ONCOL

442 ×0.8

IMMUN

Citations per year, relative to Makoto Morimoto Makoto Morimoto (= 1×) peers ISAMI TAKAHASHI

Countries citing papers authored by Makoto Morimoto

Since Specialization

Citations

This map shows the geographic impact of Makoto Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Morimoto more than expected).

Fields of papers citing papers by Makoto Morimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Morimoto. The network helps show where Makoto Morimoto may publish in the future.

Co-authorship network of co-authors of Makoto Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Morimoto. A scholar is included among the top collaborators of Makoto Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Morimoto. Makoto Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kobayashi, Hiroyuki, Yutaka Shimizu, Yuji Satoh, et al.. (2022). A 25.6-Gb/s Interface Employing PAM-4-Based Four-Channel Multiplexing and Cascaded Clock and Data Recovery Circuits in Ring Topology for High-Bandwidth and Large-Capacity Storage Systems. IEEE Journal of Solid-State Circuits. 57(5). 1517–1526. 2 indexed citations

Motomura, Eishi, Yasuhiro Kawano, Shinobu Fujii, et al.. (2021). Electrical field distribution of Change-N1 and its prepulse inhibition. Neuroscience Letters. 751. 135804–135804. 1 indexed citations

Miyashita, Daisuke, et al.. (2019). A 12.8-Gb/s Daisy Chain-Based Downlink I/F Employing Spectrally Compressed Multi-Band Multiplexing for High-Bandwidth, Large-Capacity Storage Systems. IEEE Journal of Solid-State Circuits. 54(4). 1086–1095. 4 indexed citations

Ikeda, Shun‐ichi, et al.. (1994). 6H-Pyrazolo[4,5,1-de]acridin-6-ones as a Novel Class of Antitumor Agents.Synthesis and Biological Activity. Journal of Medicinal Chemistry. 37(7). 1028–1032. 21 indexed citations

Arai, Hitoshi, Yutaka Kanda, Tadashi Ashizawa, et al.. (1994). Mitomycin derivatives having unique condensed-ring structures. Their synthesis and antitumor activity.. The Journal of Antibiotics. 47(11). 1312–1321. 1 indexed citations

Kono, Motomichi, Yutaka Saitoh, Masaji Kasai, et al.. (1993). Synthesis and structure-activity relationships of new dimeric mitomycin derivatives; 7-N,7'-N'bis(.OMEGA.-thioalkyl)dimitomycins.. The Journal of Antibiotics. 46(9). 1428–1438. 8 indexed citations

Kanda, Yutaka, Hitoshi Arai, Tadashi Ashizawa, Makoto Morimoto, & Masaji Kasai. (1992). New potent mitomycin derivatives: synthesis and antitumor activity of 7,7-(ethylenedioxy)mitomycins. Journal of Medicinal Chemistry. 35(15). 2781–2786. 5 indexed citations

Akinaga, Shiro, Tadashi Ashizawa, Katsushige Gomi, et al.. (1992). Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a and its mechanism of action. Cancer Chemotherapy and Pharmacology. 29(4). 266–272. 23 indexed citations

Akinaga, Shiro, Katsushige Gomi, Makoto Morimoto, Tatsuya Tamaoki, & Masami Okabe. (1991). Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.. PubMed. 51(18). 4888–92. 167 indexed citations

10.

Saito, Hiromitsu, Tadashi Hirata, Masaji Kasai, et al.. (1991). Synthesis and biological evaluation of quinocarcin derivatives: thioalkyl-substituted quinones and hydroquinones. Journal of Medicinal Chemistry. 34(7). 1959–1966. 17 indexed citations

11.

Saito, Hiromitsu, Akira Sato, Tadashi Ashizawa, Makoto Morimoto, & Tadashi Hirata. (1990). Synthesis of quinone derivatives of quinocarcin.. Chemical and Pharmaceutical Bulletin. 38(12). 3202–3210. 7 indexed citations

12.

Tsuruo, Takashi, et al.. (1990). Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(?-l-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 27(2). 89–93. 15 indexed citations

13.

Ogawa, T., et al.. (1989). New antitumor antibiotics, duocarmycins B1 and B2.. The Journal of Antibiotics. 42(8). 1299–1301. 52 indexed citations

14.

Hara, Mitsunobu, ISAMI TAKAHASHI, Mayumi Yoshida, et al.. (1989). DC 107, a novel antitumor antibiotic produced by a Streptomyces sp.. The Journal of Antibiotics. 42(2). 333–335. 113 indexed citations

15.

TAKAHASHI, ISAMI, Yutaka Saitoh, Mayumi Yoshida, et al.. (1989). UCN-01 and UCN-02, new selective inhibitors of protein kinase C. II. Purification, physico-chemical properties, structural determination and biological activities.. The Journal of Antibiotics. 42(4). 571–576. 136 indexed citations

16.

Kobayashi, Eiji, Katsuhiko Ando, Hirofumi Nakano, et al.. (1989). Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities.. The Journal of Antibiotics. 42(10). 1470–1474. 128 indexed citations

17.

Ichimura, Michio, Kozo Asano, Isao Kawamoto, et al.. (1988). DC89-A1, a new antitumor antibiotic from Streptomyces.. The Journal of Antibiotics. 41(9). 1285–1288. 59 indexed citations

18.

Hara, Mitsunobu, Tatsuya Tamaoki, Mayumi Yoshida, Makoto Morimoto, & Hirofumi Nakano. (1988). DC 102, a new glycosidic pyrrolo(1,4)benzodiazepine antibiotic produced by Streptomyces sp.. The Journal of Antibiotics. 41(5). 702–704. 6 indexed citations

19.

Hara, Mitsunobu, Mayumi Yoshida, Makoto Morimoto, & Hirofumi Nakano. (1987). 6-Deoxyilludin M, a new antitumor antibiotic: Fermentation, isolation and structural identification.. The Journal of Antibiotics. 40(11). 1643–1646. 12 indexed citations

20.

Gomi, Katsushige, Makoto Morimoto, & Kikuo Nomoto. (1982). Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.. The Mouseion at the JAXlibrary (Jackson Laboratory). 42(10). 4197–202. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact